CAMBRIDGE, Mass., April 22, 2026 /PRNewswire/ -- Target identification is the first and perhaps most critical step in drug discovery and development. Although the human genome contains roughly 20,000 ...

Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced ...

Barbara Slusher explains the hit-to-lead optimization process, high-throughput screening, and the role of AI and organoids in ...

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

Target-based vs phenotypic screening remains a central strategic question in modern drug discovery, particularly as research teams balance mechanistic clarity with biological relevance. Advances in ...

Target identification is a critical and challenging step in drug discovery, with only a small fraction of human genes ...